Fundies.
English

PHARMACEUTICAL PRODUCT DEVELOPMENT INC

EDGAR
Quarterly report (10-Q) · filed 2011-11-02

69 filing records in this dataset, filed from 1996-05-15 to 2011-11-02. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

415 million Unit12

2011 Q3 · Unit12

Exact inputs and evidence
  • Revenue: 415395000 Unit12 Source

Operating margin

15.75%

2011 Q3 · %

Exact inputs and evidence
  • Operating Income: 65419000 Unit12 Source
  • Revenue: 415395000 Unit12 Source

Operating cash flow

91.1 million Unit12

2011 Q3 · Unit12

Exact inputs and evidence
  • Operating Cash Flow: 150742000 Unit12 Source
  • Operating Cash Flow: 59608000 Unit12 Source

Free cash flow

77.6 million Unit12

2011 Q3 · Unit12

Exact inputs and evidence
  • Operating Cash Flow: 150742000 Unit12 Source
  • Operating Cash Flow: 59608000 Unit12 Source
  • Capital Expenditure: 61703000 Unit12 Source
  • Capital Expenditure: 48145000 Unit12 Source
Cash and cash equivalents
417 million Unit12 Source
Exact value

416746000 Unit12

Long-term debt including current maturities
Not available
Shares outstanding
119 million Unit1 Source
Exact value

119045160 Unit1

Reported share-count change

0.67% · 789 thousand Unit1

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 118256209 Unit1 · 2009-12-31· Source
  • 119045160 Unit1 · 2010-12-31· Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-11-02.

Financial data available through: 2010-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2010-12-31
  • Operating income: 3 of 11 periods available· newest 2010-12-31
  • Net income: 3 of 11 periods available· newest 2010-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2010-12-31
  • Capital expenditure: 3 of 11 periods available· newest 2010-12-31
  • Total assets: 2 of 11 periods available· newest 2010-12-31
  • Total liabilities: 2 of 11 periods available· newest 2010-12-31
  • Current assets: 2 of 11 periods available· newest 2010-12-31
  • Current liabilities: 2 of 11 periods available· newest 2010-12-31
  • Cash and cash equivalents: 3 of 11 periods available· newest 2010-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 2 of 11 periods available· newest 2010-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +3.8%

    Prior period

    Unit12 1.42 billion

    –

    Current period

    Unit12 1.47 billion

    –

    Exact inputs and evidence

    1470570000 − 1416770000 = 53800000 Unit12

    1416770000 Unit12 · 2009-01-01 – 2009-12-31

    Inspect prior input Prior source

    1470570000 Unit12 · 2010-01-01 – 2010-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    -22.4%

    Prior period

    Unit12 159.3 million

    –

    Current period

    Unit12 123.67 million

    –

    Exact inputs and evidence

    123667000 − 159295000 = -35628000 Unit12

    159295000 Unit12 · 2009-01-01 – 2009-12-31

    Inspect prior input Prior source

    123667000 Unit12 · 2010-01-01 – 2010-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    -2.1%

    Prior period

    Unit12 253 million

    –

    Current period

    Unit12 247.75 million

    –

    Exact inputs and evidence

    247745000 − 252998000 = -5253000 Unit12

    252998000 Unit12 · 2009-01-01 – 2009-12-31

    Inspect prior input Prior source

    247745000 Unit12 · 2010-01-01 – 2010-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +14.4%

    Prior period

    Unit12 54.68 million

    –

    Current period

    Unit12 62.52 million

    –

    Exact inputs and evidence

    62524000 − 54677000 = 7847000 Unit12

    54677000 Unit12 · 2009-01-01 – 2009-12-31

    Inspect prior input Prior source

    62524000 Unit12 · 2010-01-01 – 2010-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2010-01-01 – 2010-12-31

  • Revenue Unit12 1.47 billion 100% of revenue
  • Operating costs Derived Unit12 1.28 billion 87% of revenue
  • Operating income Unit12 187.45 million 13% of revenue
  • Tax, interest and other Derived Unit12 63.79 million 4.3% of revenue
  • Net income Unit12 123.67 million 8.4% of revenue

Cash

  • Operating cash flow Unit12 247.75 million 17% of revenue
  • Capital expenditure Unit12 62.52 million 4.3% of revenue
  • Free cash flow Derived Unit12 185.22 million 13% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2008 12%82%
  • 2009 11%85%
  • 2010 87%
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2008 2008-01-01 – 2008-12-311551384000 1268987000 Derived 282397000 94878000 Derived 187519000 313593000 Derived
Source
2009 2009-01-01 – 2009-12-311416770000 1202465000 Derived 214305000 55010000 Derived 159295000 198321000 Derived
Source
2010 2010-01-01 – 2010-12-311470570000 1283118000 Derived 187452000 63785000 Derived 123667000 185221000 Derived
Source

Amounts are exact, in Unit12.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit12 1.5B 2010
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.7B1.3B837.7M418.9M0.0200820092010
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit12)Source evidence
2008Revenue1551384000
2009Revenue1416770000
2010Revenue1470570000

Revenue growth

Change in revenue from the same financial period one year earlier.

3.8% 2010
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4.8%1.2%-2.4%-6.1%-9.7%200820092010
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2008Year over yearNo prior comparable period
2009Year over year-8.7%
2010Year over year3.8%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 12.7% 2010
Net margin 8.4% 2010
Free cash flow margin 12.6% 2010
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.21.8%16.4%10.9%5.5%0.0%200820092010
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2008Operating margin18.2%
2009Operating margin15.1%
2010Operating margin12.7%
2008Net margin12.1%
2009Net margin11.2%
2010Net margin8.4%
2008Free cash flow margin20.2%
2009Free cash flow margin14%
2010Free cash flow margin12.6%

Operating cash flow

Cash generated by the company’s normal business operations.

Unit12 247.7M 2010
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.410.9M308.2M205.5M102.7M0.0200820092010
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit12)Source evidence
2008Operating cash flow380477000
2009Operating cash flow252998000
2010Operating cash flow247745000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit12 185.2M 2010
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.338.7M254.0M169.3M84.7M0.0200820092010
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit12)Source evidence
2008Free cash flow313593000
2009Free cash flow198321000
2010Free cash flow185221000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

35.2% 2010
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.38.0%28.5%19.0%9.5%0.0%2008-12-3120092010
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2008-12-31Liabilities / assetsNot reportedNo source recorded
2009Liabilities / assets33.7%
2010Liabilities / assets35.2%

Current assets to current liabilities

Current assets divided by current liabilities.

1.85× 2010
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.07×1.55×1.03×0.52×0.00×2008-12-3120092010
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2008-12-31Current assets / current liabilitiesNot reportedNo source recorded
2009Current assets / current liabilities1.92×
2010Current assets / current liabilities1.85×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2008 2008-01-01 – 2008-12-31
Unit12 187.52 million
Exact value

Exact value: 187519000 Unit12

2008-01-01 – 2008-12-31: 187519000 Unit12 Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit12 380.48 million
Exact value

Exact value: 380477000 Unit12

2008-01-01 – 2008-12-31: 380477000 Unit12 Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit12 66.88 million
Exact value

Exact value: 66884000 Unit12

2008-01-01 – 2008-12-31: 66884000 Unit12 Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit12 313.59 million
Calculation and evidence

380477000 − 66884000 Unit12

Exact free cash flow: 313593000 Unit12

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2009 2009-01-01 – 2009-12-31
Unit12 159.3 million
Exact value

Exact value: 159295000 Unit12

2009-01-01 – 2009-12-31: 159295000 Unit12 Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit12 253 million
Exact value

Exact value: 252998000 Unit12

2009-01-01 – 2009-12-31: 252998000 Unit12 Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit12 54.68 million
Exact value

Exact value: 54677000 Unit12

2009-01-01 – 2009-12-31: 54677000 Unit12 Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit12 198.32 million
Calculation and evidence

252998000 − 54677000 Unit12

Exact free cash flow: 198321000 Unit12

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2010 2010-01-01 – 2010-12-31
Unit12 123.67 million
Exact value

Exact value: 123667000 Unit12

2010-01-01 – 2010-12-31: 123667000 Unit12 Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit12 247.75 million
Exact value

Exact value: 247745000 Unit12

2010-01-01 – 2010-12-31: 247745000 Unit12 Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit12 62.52 million
Exact value

Exact value: 62524000 Unit12

2010-01-01 – 2010-12-31: 62524000 Unit12 Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit12 185.22 million
Calculation and evidence

247745000 − 62524000 Unit12

Exact free cash flow: 185221000 Unit12

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

69 filings · 619 latest values · 619 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001003124, 1003124, edgar:1003124

Also known as PHARMACEUTICAL PRODUCT DEVELOPMENT INC, PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC